cambridgesoft -- virtualized pharma in 2020
DESCRIPTION
The Pistoia Alliance Conference in April 2011 included a series of 10-minute "lightning talks" from vendors about what they think pharma will look like in 2020. This presentation was delivered by John P. McAlister of CambridgeSoft.TRANSCRIPT
April 2011 John P. McAlister
Pistoia Alliance – Virtualized Pharma in 2020
Page 2
Industry in Throes of Change
Industry business strategies revisited
Cost control is increasingly a decision driver Strategy is in flux at large pharma players
Focus on sales and marketing or continue strong investment in R&D? Network research activities with other pharmas and cross-license IP? Invest in “centers of excellence” (internal or external) or traditional model?
Benefits of small, entrepreneurial research environment
Industry consolidation, reorganization
Industry players, customers & suppliers consolidate and divest Global operations optimized – strategic diversification
Based on markets, costs, resources
Rapid Innovation (science and technology)
‘Omics, diagnostics/patient segregation, new therapeutic strategies Translational medicine reduced to practice
Page 3
Information Systems – Enabling Strategic Options
Capture and manage all aspects of research information from the enterprise?
Globally distributed systems will be the norm – likely cloud-based Industry will require fine control of access to system and content Traditional “discipline-focused” systems area insufficient
Link to medical systems to access outcomes information directly
New procedures will be required to protect patient information Assume that each subject will have full genomic information available along with relevant
proteome and metabolome
Capture post-market information to assess and fine-tune product
Incorporate analytical methods that include inference engines, hypothesis generation and analysis platforms
Models are too simplistic for the current range of diseases Multidimensional parameter spaces demand novel methods for analysis and interpretation
Page 4
Research Information Systems• Replace paper-based workflows with detailed e-workflows across the full range of life
science business areas
• Apply decision support methods to support research
Chemistry Biology ‘Omic InfoMedical
OutcomesMarket
Surveillance
Searchable DB
Strategic Decisions
Page 5
Information Systems – The Future
No single supplier will provide all information systems required by research enterprise
Specialty-based systems are already available across the disciplines Consolidation of closely related suppliers is inevitable, generating powerful large players
Innovative small startups will quickly be targeted for acquisition
Systems implementation will be a major component of the enterprise
Cross-functional team expertise will be the gold-standard of the future Standards-based APIs are essential
Collaborative relationships among major informatics suppliers will be essential for pharma research and development information systems delivery
Page 6